Gilead Sciences GILD Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gilead Sciences's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gilead Sciences's deferred tax assets?
- Gilead Sciences (GILD) reported deferred tax assets of $179M in Q1 2026.
- How has Gilead Sciences's deferred tax assets changed year-over-year?
- Gilead Sciences's deferred tax assets decreased by 74.8% year-over-year, from $709M to $179M.
- What is the long-term trend for Gilead Sciences's deferred tax assets?
- Over 4 years (2021 to 2025), Gilead Sciences's deferred tax assets has grown at a -39.7% compound annual growth rate (CAGR), from $17.8B to $2.36B.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.